Changes in CDC6 gene expression have been reported in many species of cancers (Figures 1A, B), such as gastric cancer (21, 22), pancreatic cancer (23), prostate cancer (24) and so on, related to cancer cell proliferation, metastasis, invasiveness and drug resistance. This evidence concerns the gene CDC6 and familial pancreatic carcinoma.